Related Experiment Videos

Growth inhibition by homofolate in tumor cells utilizing a high-affinity folate binding protein as a means for folate

G B Henderson1, B P Strauss

  • 1Department of Molecular and Experimental Medicine, Scripps Clinic and Research Foundation, La Jolla, CA 92037.

Insights

Homofolate inhibits L1210 leukemia cell growth by targeting a high-affinity folate binding protein. This folate analog competes for uptake, demonstrating its potential as a targeted therapeutic agent.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • L1210 mouse leukemia cells exhibit varying folate uptake mechanisms.
  • A specific subline, JT-1, overexpresses a high-affinity folate binding protein.
  • Folate binding proteins are crucial for cellular folate acquisition.

Purpose of the Study:

  • To investigate the effect of homofolate on L1210/JT-1 cell growth.
  • To determine the role of the high-affinity folate binding protein in homofolate sensitivity.
  • To elucidate the mechanism of homofolate-mediated growth inhibition.

Main Methods:

  • Cell culture of L1210/JT-1 and parental L1210 cells.
  • Growth inhibition assays with varying concentrations of homofolate, folate, and 5-formyltetrahydrofolate.
  • Folate uptake studies using radiolabeled folate.
  • Binding assays to determine homofolate affinity for folate binding protein and reduced-folate transport system.

Main Results:

  • Homofolate caused significant growth inhibition of L1210/JT-1 cells at nanomolar concentrations.
  • Inhibition correlated with homofolate's ability to block folate uptake via the high-affinity folate binding protein.
  • Parental cells lacking the binding protein were resistant to homofolate.
  • Homofolate exhibited high affinity for the folate binding protein but poor affinity for the reduced-folate transport system.

Conclusions:

  • Homofolate inhibits L1210 cell growth specifically when folate uptake occurs through the high-affinity folate binding protein.
  • The mechanism involves homofolate competing for substrate binding and internalization.
  • This highlights the potential of targeting folate binding proteins for cancer therapy.

Related Concept Videos